Christopher P. Mill
- Immunology and Allergy top 2%
- Food Allergy and Anaphylaxis Research 10
- Hematology top 2%
- Acute Myeloid Leukemia Research 27
- Multiple Myeloma Research and Treatments 9
- Toxicology top 5%
- Dermatology top 5%
- Pharmacology top 5%
-
- Protein Degradation and Inhibitors 30
- Histone Deacetylase Inhibitors Research 9
-
- HER2/EGFR in Cancer Research 9
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Sarah J. GeorgeDavid J. RieseKapil N. BhallaWarren FiskusMoshe Ben‐ShoshanAndrew O’KeefeAlizée DeryTapan M. Kadia
- Partner nations
- United StatesCanadaSweden
In The Last Decade
Christopher P. Mill
69 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Immunology and Allergy 260
- Hematology 390
- Toxicology 72
- Dermatology 132
- Pharmacology 240
Countries citing papers authored by Christopher P. Mill
This map shows the geographic impact of Christopher P. Mill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Mill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Mill more than expected).
Fields of papers citing papers by Christopher P. Mill
This network shows the impact of papers produced by Christopher P. Mill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Mill. The network helps show where Christopher P. Mill may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher P. Mill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 33 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 73 | |
| 12 | 2021 | 48 | |
| 13 | 2021 | 36 | |
| 14 | 2020 | 52 | |
| 15 | 2020 | 2 | |
| 16 | 2019 | 16 | |
| 17 | 2017 | 1 | |
| 18 | 2016 | 57 | |
| 19 | 2012 | 5 | |
| 20 | 2007 | 13 |
About Christopher P. Mill
Christopher P. Mill is a scholar working on Hematology, Immunology and Allergy, Molecular Biology, Genetics and Oncology, having authored 82 papers that have together received 1.8k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (30 papers), Acute Myeloid Leukemia Research (27 papers), Food Allergy and Anaphylaxis Research (10 papers), Multiple Myeloma Research and Treatments (9 papers), Histone Deacetylase Inhibitors Research (9 papers), HER2/EGFR in Cancer Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Immunology and Allergy (260 citations), Hematology (390 citations), Toxicology (72 citations), Dermatology (132 citations) and Pharmacology (240 citations). Christopher P. Mill has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Sarah J. George, David J. Riese, Kapil N. Bhalla, Warren Fiskus, Moshe Ben‐Shoshan, Andrew O’Keefe, Alizée Dery, Tapan M. Kadia, Christine Lejtenyi and Marie-Noël Primeau. Their work appears in journals such as Blood, Leukemia, Cancer Research, Blood Cancer Journal and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.